For two of the three proteins that were decreased in T2D compared to controls, our findings here are in accord with the findings reported in IGT, where adiponectin and endocan were two of the top differentially expressed proteins that were found to be decreased in those with IGT and reduced β-cell sensitivity [15]. The gene discussed is ESM1; the disease is type 2 diabetes mellitus.